Market Cap 499.90B
Revenue (ttm) 88.82B
Net Income (ttm) 14.07B
EPS (ttm) N/A
PE Ratio 19.73
Forward PE 17.82
Profit Margin 15.84%
Debt to Equity Ratio 0.50
Volume 6,557,700
Avg Vol 8,467,358
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 57%
Beta 0.34
Analysts Strong Sell
Price Target $212.58

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
ZacksResearch
ZacksResearch Jan. 9 at 4:10 PM
$JNJ inks a landmark deal with the government — what’s the catch? The pharma giant agreed to slash drug prices to match developed nations, in exchange for tariff exemptions and a push to expand U.S. manufacturing. Discover the full implications here 👉 https://www.zacks.com/stock/news/2815106/jj-strikes-drug-pricing-deal-with-trump-gets-tariff-reprieve?cid=sm-stocktwits-2-2815106-body-28216&ADID=SYND_STOCKTWITS_TWEET_2_2815106_BODY_28216
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Jan. 9 at 4:10 PM
$CMPS Every day that passes, is a day closer to approval, Topline results. 10-15+ supports incoming, nice donations now for sub 10 right now. Thank them and take their shares. The Willow Tree bark has aspirin, it's where aspirin comes from, ( historically where it was discovered, bark is not used anymore for aspirin, like COMP360, it is fully synthesized from raw ingredients) but nobody buys bark for an imperfect dose of Aspirin. Mushrooms decay, are difficult to grow, while our synthesized version, in crystalline form, polymorph A, DOESN'T SPOIL OR DECAY, AND HAS YEARS AND YEARS OF SHELF LIFE, IN CRYSTALINE FORM LIKE SALT. LONG. $ATAI $MNMD $JNJ $LLY
0 · Reply
th66
th66 Jan. 9 at 3:42 PM
$JNJ Heavily manipulated mm won't let it move up on excellent news
0 · Reply
ZacksResearch
ZacksResearch Jan. 9 at 3:10 PM
$JNJ just made a big political move — and the market’s paying attention The company struck a deal to cut U.S. drug prices, secured a tariff reprieve, and is accelerating a $55B push to expand domestic manufacturing — a major shift with real financial implications. What this deal really means for the stock 👉 https://www.zacks.com/stock/news/2815106/jj-strikes-drug-pricing-deal-with-trump-gets-tariff-reprieve?cid=sm-stocktwits-2-2815106-teaser-28189&ADID=SYND_STOCKTWITS_TWEET_2_2815106_TEASER_28189
0 · Reply
th66
th66 Jan. 9 at 2:46 PM
$JNJ What's it going to take to move this up. Tremendous news and still stuck
0 · Reply
Bazzzigar
Bazzzigar Jan. 9 at 1:54 PM
$JNJ bad decision to sign
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 9 at 1:42 PM
$JNJ (+0.0% pre) J&J strikes deal with US government to cut drug prices, gain tariff exemptions https://ooc.bz/l/89197
0 · Reply
Arunas1
Arunas1 Jan. 9 at 1:26 PM
0 · Reply
FluxCore_06
FluxCore_06 Jan. 9 at 12:31 PM
$JNJ defensive flow tells you the market mood, watch if it starts catching bids on red index days
0 · Reply
Suite510
Suite510 Jan. 9 at 12:27 PM
$JNJ $KVUE Reduced drug prices due to the Trump surrender agreement, plus talc billion dollar verdicts 🥵🤣
0 · Reply
Latest News on JNJ
Cramer's Mad Dash: Johnson & Johnson

Jan 9, 2026, 9:59 AM EST - 1 hour ago

Cramer's Mad Dash: Johnson & Johnson


Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 9 days ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


The Big 3: JNJ, SNDK, TWLO

Dec 30, 2025, 1:31 PM EST - 9 days ago

The Big 3: JNJ, SNDK, TWLO

TWLO SNDK


More Upside For JNJ Stock In 2026?

Dec 30, 2025, 5:05 AM EST - 10 days ago

More Upside For JNJ Stock In 2026?


Dogs of the Dow Had a Strong Year as Dividends Paid Off

Dec 29, 2025, 1:56 PM EST - 10 days ago

Dogs of the Dow Had a Strong Year as Dividends Paid Off

HD IBM NKE UNH


Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 12 days ago

Best Dividend Kings: December 2025

ABBV ABM ABT ADM ADP AWR BDX


Final Trade: JNJ, NVO, UBER, BMY

Dec 15, 2025, 6:22 PM EST - 24 days ago

Final Trade: JNJ, NVO, UBER, BMY

BMY NVO UBER


US FDA grants priority voucher to J&J's blood cancer treatment

Dec 15, 2025, 10:39 AM EST - 25 days ago

US FDA grants priority voucher to J&J's blood cancer treatment


Johnson & Johnson: Reliable Cash Flows, Moderate Expectations

Dec 11, 2025, 7:05 PM EST - 4 weeks ago

Johnson & Johnson: Reliable Cash Flows, Moderate Expectations


16 Quality Stocks to Own for a Volatile Market

Dec 1, 2025, 1:23 PM EST - 5 weeks ago

16 Quality Stocks to Own for a Volatile Market

CSCO LLY XOM


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 5 weeks ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR


Dogs Of The Dow Continue Outperforming Broader Market

Nov 29, 2025, 1:45 AM EST - 5 weeks ago

Dogs Of The Dow Continue Outperforming Broader Market

AMGN DIA MAGS SPY


Wasatch Global Value Fund Q3 2025 Performance Review

Nov 28, 2025, 7:50 AM EST - 6 weeks ago

Wasatch Global Value Fund Q3 2025 Performance Review

BABA CNC DOX NVDA


ZacksResearch
ZacksResearch Jan. 9 at 4:10 PM
$JNJ inks a landmark deal with the government — what’s the catch? The pharma giant agreed to slash drug prices to match developed nations, in exchange for tariff exemptions and a push to expand U.S. manufacturing. Discover the full implications here 👉 https://www.zacks.com/stock/news/2815106/jj-strikes-drug-pricing-deal-with-trump-gets-tariff-reprieve?cid=sm-stocktwits-2-2815106-body-28216&ADID=SYND_STOCKTWITS_TWEET_2_2815106_BODY_28216
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Jan. 9 at 4:10 PM
$CMPS Every day that passes, is a day closer to approval, Topline results. 10-15+ supports incoming, nice donations now for sub 10 right now. Thank them and take their shares. The Willow Tree bark has aspirin, it's where aspirin comes from, ( historically where it was discovered, bark is not used anymore for aspirin, like COMP360, it is fully synthesized from raw ingredients) but nobody buys bark for an imperfect dose of Aspirin. Mushrooms decay, are difficult to grow, while our synthesized version, in crystalline form, polymorph A, DOESN'T SPOIL OR DECAY, AND HAS YEARS AND YEARS OF SHELF LIFE, IN CRYSTALINE FORM LIKE SALT. LONG. $ATAI $MNMD $JNJ $LLY
0 · Reply
th66
th66 Jan. 9 at 3:42 PM
$JNJ Heavily manipulated mm won't let it move up on excellent news
0 · Reply
ZacksResearch
ZacksResearch Jan. 9 at 3:10 PM
$JNJ just made a big political move — and the market’s paying attention The company struck a deal to cut U.S. drug prices, secured a tariff reprieve, and is accelerating a $55B push to expand domestic manufacturing — a major shift with real financial implications. What this deal really means for the stock 👉 https://www.zacks.com/stock/news/2815106/jj-strikes-drug-pricing-deal-with-trump-gets-tariff-reprieve?cid=sm-stocktwits-2-2815106-teaser-28189&ADID=SYND_STOCKTWITS_TWEET_2_2815106_TEASER_28189
0 · Reply
th66
th66 Jan. 9 at 2:46 PM
$JNJ What's it going to take to move this up. Tremendous news and still stuck
0 · Reply
Bazzzigar
Bazzzigar Jan. 9 at 1:54 PM
$JNJ bad decision to sign
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 9 at 1:42 PM
$JNJ (+0.0% pre) J&J strikes deal with US government to cut drug prices, gain tariff exemptions https://ooc.bz/l/89197
0 · Reply
Arunas1
Arunas1 Jan. 9 at 1:26 PM
0 · Reply
FluxCore_06
FluxCore_06 Jan. 9 at 12:31 PM
$JNJ defensive flow tells you the market mood, watch if it starts catching bids on red index days
0 · Reply
Suite510
Suite510 Jan. 9 at 12:27 PM
$JNJ $KVUE Reduced drug prices due to the Trump surrender agreement, plus talc billion dollar verdicts 🥵🤣
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Jan. 9 at 12:14 PM
0 · Reply
Bazzzigar
Bazzzigar Jan. 9 at 12:11 PM
$JNJ Terrible
0 · Reply
603stockgoat
603stockgoat Jan. 9 at 12:01 PM
$GLSI 150 shares today, everyone buy, squeeze these 🩳 $SPY $LLY $JNJ
0 · Reply
mikesterz7
mikesterz7 Jan. 9 at 11:44 AM
$JNJ The company will also provide U.S. Medicaid programs access to medicines at prices comparable to those in other developed countries.
0 · Reply
Arunas1
Arunas1 Jan. 9 at 11:32 AM
$MRNA slides to $27 🎯 . $BMY $MRK $JNJ 👑🧞‍♂️👑
1 · Reply
Arunas1
Arunas1 Jan. 9 at 11:14 AM
$JNJ Extreme High Probability JNJ stock dips to $193.00 today $SPY $DIA $QQQ 👑🧞‍♂️👑
0 · Reply
Arunas1
Arunas1 Jan. 9 at 11:12 AM
$JNJ on this news! Gap down $192 - $180 today 👑🧞‍♂️👑
0 · Reply
Arunas1
Arunas1 Jan. 9 at 11:08 AM
$JNJ gaps down to $180’s 🧞‍♂️.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 9 at 4:50 AM
$JNJ Your price target went up from $180 to $191 in one hour. You don’t even believe the garbage you post. Go ask Santa for more predictions you clown.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 9 at 4:46 AM
$JNJ $KVUE The dumbest of the bots with another irrelevant post.
0 · Reply
AlertsAndNews
AlertsAndNews Jan. 9 at 3:34 AM
$JNJ Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments Johnson & Johnson said it reached a voluntary agreement with the Trump administration aimed at improving access to medicines and lowering costs for millions of Americans. Under the agreement, J&J’s pharmaceutical products will receive exemptions from U.S. tariffs, while allowing patients to purchase certain medicines at significantly discounted rates. The company also announced plans to build two additional manufacturing facilities in North Carolina and Pennsylvania, advancing its previously disclosed $55 billion U.S. investment commitment.
0 · Reply
JohnTrack
JohnTrack Jan. 9 at 3:16 AM
$JNJ watching for higher lows...
0 · Reply